Abstract: An input device includes a control surface for a color correction system. The control surface includes a housing with an upwardly facing control panel. The control panel has a proximal edge which is nearest a user and a distal edge that is furthest from a user in normal use. The control panel includes a plurality of controls. The plurality of controls includes: a plurality of trackballs, wherein each trackball comprises a ball and a control ring, said ball cooperating with at least one encoder to generate a multi-dimensional control signal based on motion of the ball, and said control ring cooperating with at least one encoder to generate a one dimensional control signal based on the rotational motion of the ring, wherein the ball of said trackball is mounted concentrically with said control ring; a plurality of control buttons; and a plurality of knobs coupled to respective rotary encoders.

Abstract: Provided herein are systems and methods for the prediction of recurrent cancer in a subject and systems and methods for using the prediction in the treatment or prevention of cancer recurrence.

Abstract: The present invention comprises, without limitation, methods and apparatus to induce changes in eukaryotic cell shapes by application of low-level electric or magnetic fields and thereby to impact cell function or mobility. Thus, the present invention comprises methods and apparatus for the investigation and treatment of human and animal diseases, conditions, and defects.

Abstract: The present invention relates, in general, to phagocytosis and phagolysosomal fusion and, in particular, to a tripeptide of Fc?RIIA that mediates trafficking of targets phagocytosed via Fc?RIIA to the lysosomal compartment.

Abstract: The present invention relates to methods for inhibiting tumor cell metastasis in cancer comprising administering a composition comprising a T-type calcium channel inhibitor, such as mibefradil.

Abstract: A method and apparatus for measuring the retinal auto-fluorescence of a subject retina includes an excitation light source for providing an excitation light at a wavelength of at least 450 nm and an image capture device for recording an ocular auto-fluorescence signal generated in response to the excitation light. The image capture device includes a filter for reducing background non-signal wavelengths from the ocular auto-fluorescence signal and an image intensifier for increasing the ocular auto-fluorescence signal strength. The method and apparatus may further include a processor that analyzes the ocular auto-fluorescence signal to determine a contrast change or pattern to thereby detect retinal disease or damage. The processor may compare the images with control images, past images of the same eye or other diagnostic modalities such as fundus photography, angiography, or visual field testing to detect the retinal disease or damage.